CLINICAL_TRIALS
trial_result
· 2024-07-29
Clinical Trial Update: Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma [Phase 2]
Summary
A Phase 2 trial evaluating trabectedin in combination with olaparib for advanced unresectable or metastatic sarcoma has completed, with results posted in 2024-0…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Sarcoma, Sarcoma Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2024-07-29